Hesquijarosa Alexander MD is categorized under Doctors in New Canaan, CT and active since 2010.
Hesquijarosa Alexander MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Alexander Hesquijarosa at the company’s single location by writing to 173 East Avenue, New Canaan, Connecticut CT 06840 or by phoning (203) 972-4255. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Hesquijarosa Alexander MD |
| Contact Person: | Alexander Hesquijarosa |
| Address: | 173 East Avenue, New Canaan, Connecticut 06840 |
| Phone Number: | (203) 972-4255 |
| Website Address: | newcanaanmedical.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Hesquijarosa Alexander MD was started in 2010 to provide professional Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Alexander Hesquijarosa for inquiries that concern Hesquijarosa Alexander MD by calling the company number (203) 972-4255, as your correspondence is most welcome. Additionally, the physical location of the single location of Hesquijarosa Alexander MD can be found at the coordinates 41.14744,-73.4846 as well as the street address 173 East Avenue in New Canaan, Connecticut 06840.
For its online presence, you may visit Hesquijarosa Alexander MD’s website at newcanaanmedical.com and engage with its social media outlets through on Twitter and on Facebook.